StocksMedium•6 October 2026•
1 min read
GE HealthCare to Acquire SOFIE Biosciences in $945 Million Deal
Key Facts
1GE HealthCare announced a $945 million deal to acquire SOFIE Biosciences, a specialist in radiopharmaceuticals.
GE HealthCare announced a $945 million deal to acquire SOFIE Biosciences, a specialist in radiopharmaceuticals. Zacks reported that the agreement is designed to expand the company's PET radiopharmaceutical footprint across the United States.
The acquisition aims to boost GE HealthCare's exposure to the precision care growth market while enhancing its radiopharmaceutical manufacturing and distribution capabilities. This strategic move focuses on strengthening the company's logistical and clinical infrastructure in high-growth medical sectors.